As of 10:08am ET
| 0.00005 / +0.06%|
Amarantus Bioscience Holdings, Inc. is a development stage biotechnology company, which engages in discovering and developing treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis. It develops and owns intellectual property and proprietary technology to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.
|There are no executives to display.|